Figure 7
From: Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion
Proliferation of CL1–5 (a) and benign mesothelial (b) cells after treatment with PAM. The numbers of living cells were counted on days 0, 2, 4, 6, and 8. Data are mean and SD values (n = 3). Mobility of CL1–5 (c) and benign mesothelial (d) cells after the treatment with PAM was determined using a scratch assay. Data are mean and SD values (n = 3). * P < 0.05; ** P < 0.01 (Student’s t test).
